Monthly Newsletter

Oxford Global are proud to present the 7th Annual Next Generation Sequencing Congress taking place on 12th and 13th November 2015 at the Novotel London West, UK. Over the two days this prestigious congress will bring together over 400 senior level attendees from both academia and pharma to discuss the most crucial challenges in the next generation sequencing field.

The global NGS market is estimated to be worth $2.7 billion by 2017, double the value recorded in 2012. The tremendous advances in next generation sequencing technologies and platforms are opening fascinating opportunities in life science research. Novel discoveries identifying genetic mutations and genomic alterations have allowed for new opportunities in health and disease research.

Over the two days the Next Generation Sequencing Congress will cover presentations on the latest technologies and platforms including whole genome sequencing, ion torrent, nanopore technologies and third generation sequencing. Presentations will also include the use of NGS in human disease, microbiology and nutrition. In the NGS Data stream hear from leading academics discussing novel data analysis technologies and platforms. Topics will include: data analysis tools for integrating technologies and ’omics data sets, comparison of NGS platforms and metagenomics data analysis challenges.

For further information click here